• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Yehuda Handelsman Discusses New Alternatives to Basal Insulin

News
Video

Recent advances in insulin formulations and innovative drug classes have made it easier than ever to manage diabetic patients’ glucose levels, according to Yehuda Handelsman, MD, FACP, FACE, FNLA, medical director and principal investigator at the Metabolic Institute of America.

Recent advances in insulin formulations and innovative drug classes have made it easier than ever to manage diabetic patients’ glucose levels, according to Yehuda Handelsman, MD, FACP, FACE, FNLA, medical director and principal investigator at the Metabolic Institute of America.

Related Videos
Jessica Horwitz, MPH, FNP-C.
Craig A. Portell, MD, UVA Health
Jonathan Strober, MD, UCSF Benioff Children's Hospital
Eboni Price-Haywood, MD and Toni Flowers, PhD
Natalie Bedford sitting for a video interview
Dr Raymond Osarogiagbon
Christine Funke, MD
Dr Raymond Osarogiagbon
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.